Extracorporeal Hyperthermia Perfusion (EHP) | Centre of Advanced Medicine, Frankfurt, Germany

Introducing Extracorporeal Hyperthermia Perfusion (EHP), an innovative therapy that combines the best of hemoperfusion, hyperthermia, oxygenation, and apheresis to treat a wide range of health conditions. From cancers and Lyme disease to autoimmune diseases, chronic illnesses, and heavy metal pollution-related disorders, the therapy is highly effective and minimizes the risk of side effects. With EHP, you can take control of your health and experience the benefits of a comprehensive, self-contained treatment. The EHP consists of the following. Hemo-hyperthermia. Hemo-hyperthermia is a unique method of cancer treatment that involves warming the blood to a specific temperature range of 40°C to 42. 0°C and then injecting it into the body. Unlike other hyperthermia methods that warm the body from the outside, hemo-hyperthermia directly warms the blood, allowing for higher concentrations of cytostatic drugs to be delivered directly to the affected target organs. This method is particularly effective in cancer treatment because it enables the cytostatics to be delivered in much higher concentrations than in conventional chemotherapies, resulting in a more targeted and effective treatment with fewer side effects. Additionally, the excess of cytostatics can be removed from the organism at the end of the treatment with a special technique, further reducing the possibility of side effects. Hemoperfusion. Hemoperfusion is a medical procedure that removes harmful and inflammatory molecules from the human blood. This helps regulate metabolism, boost the immune system, and improve the effectiveness of various medication strategies. At our facility, we use different techniques to remove heavy metal contamination from the blood in just one treatment. First, chelating agents are infused to channel heavy metals from the tissues into the blood, and heat is then applied to maximize this process. The heavy metals are then filtered from the blood. Our hemoperfusion procedure is suitable for treating sepsis, severe inflammation, cytokines, and various toxins. It is also effective for treating Lyme disease, autoimmune diseases, cancer, multiple organ failure, liver and kidney diseases, systemic inflammatory response syndrome (SIRS), lung diseases such as acute respiratory distress syndrome (ARDS), and other blood-related conditions. This treatment significantly increases effectiveness and can provide numerous benefits to patients. Hyperoxygenated hemoperfusion. Hemoperfusion can be extended by using an oxygenator that was originally developed for cardiac surgery but is now utilized in numerous therapeutic disciplines. By introducing medical oxygen, the saturation of oxygen in the tissue can exceed 700%. This high level of oxygen saturation triggers the body's own repair and regeneration processes while stimulating neovascularization and enhancing the discharge of toxins from the organism. The EHP has revolutionized the treatment of various medical conditions by enabling a constant stream temperature of up to 42. 0 °C to be maintained in the body for more than 3 hours. This temperature control technology is highly effective in treating a range of conditions with minimal impact on the patient. What are the indications?Autoimmune diseases (such as multiple sclerosis, Crohn’s disease, ulcerative colitis, Hashimoto’s thyroiditis and many others);Lyme disease;Cancer;Liver disease;Lung disease (ARDS);Kidney disease;Sepsis;Suspected multiple organ failure;Heavy metal pollution;Rheumatic disorders (arthritis, arthrosis, gout etc. ).